Navigation Links
Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies
Date:4/21/2008

, transdermal continuous glucose monitoring (tCGM) system for people with diabetes and for use in hospital critical care units. Echo is also developing a wide range of proprietary transdermal reformulations of FDA-approved pharmaceutical products.

About Cato BioVentures

Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization. For 20 years, Cato BioVentures has assisted entrepreneurs and established management teams in building successful pharmaceutical and biotechnology companies. Through strategic CRO service agreements with Cato Research, Cato BioVentures invests its in-kind CRO Service Capital(TM) in innovative products and technologies, giving promising companies immediate access to a broad range of essential CRO services on a noncash basis.

About Cato Research

Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, Cato Research is a global full-service contract research and development organization (CRO) providing strategic and tactical support for clients in the pharmaceutical, biotechnology and medical device industries. Cato Research has a staff of over 300 located in offices in the United States, European Union, Canada, Israel, and South Africa.

Cautionary Statement Regarding Forward Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward- looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks related to Echo's or its partners' ability to identify and obtain additional dermatology product candidates or transdermal dru
'/>"/>

SOURCE Echo Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 CHI-California Healthcare Institute today unveiled ... hepatitis C (hep C) epidemic in the U.S., the ... to reduce human suffering. The report examines key data ... hep C, while highlighting the significance of breakthroughs that ... CHI is a nonprofit, public policy research organization, representing ...
(Date:7/29/2014)... The Latin American poultry feed and feed additive ... forecast of revenue. The poultry feed and feed additive market ... and $647.2 million in 2013 to $34,024.0 million and $870.1 ... to 2018, respectively. , To get an idea of the ... the Latin American poultry feed and feed additive market report. ...
(Date:7/29/2014)... The Los Angeles based drug and ... a community program that helps homeless families in the ... the San Fernando Valley Rescue Mission to provide a ... Fernando Valley Rescue Mission offers emergency shelter and services ... Shelter provides housing and basic needs such as food ...
(Date:7/29/2014)... Frank Davis, Activz Founder and CEO, ... add nutrition to their kids’ meals in the ... drivers in kids’ foods market” by Kaylynn Chiarello-Ebner. , ... the interview Frank Davis had with Kaylynn Chiarello-Ebner, about ... and fruit produce powders to kids meals, was successfully ...
(Date:7/29/2014)... HealthDay Reporter MONDAY, July ... that continues to rage throughout West Africa poses little risk ... spreads through physical touch, and it can,t be spread by ... director of the National Center for Emerging & Zoonotic Infectious ... explained in a Monday afternoon news conference. Those factors ...
Breaking Medicine News(10 mins):Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5Health News:The Discovery House Employees Volunteer at Local Rescue Mission 2Health News:The Discovery House Employees Volunteer at Local Rescue Mission 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:CDC Downplays Ebola's Threat to the United States 2Health News:CDC Downplays Ebola's Threat to the United States 3Health News:CDC Downplays Ebola's Threat to the United States 4
... each developed by Merck and Smith Glaxo Kline has found ... caused by the human papilloma viruses (HPVs). ... reduced infection in about 90% of the subjects. ... immunologic technologies have contributed to the discovery of the link ...
... revealed that having several older brothers increases the chances of ... //weight to the idea of a biological basis for sexual ... in St Catharines, Canada said, "It's likely to be a ... probably a biological basis for homosexuality." ,S Marc ...
... Graham Burton, M.D., SVP, Regulatory Affairs and Pharmacovigilance ... a new oral drug option// to the group ... ,Celgene Corporation (Nasdaq: CELG) announced that the U.S. ... for its Supplemental New Drug Application (sNDA) for ...
... had stated on Friday that the precedent conditions of ... outbreak at Durban's Mahatma Gandhi Memorial Hospital, which had ... Mseleku said, “Nobody needs to communicate these problems. We ... It's (overcrowding and staff shortages) a known fact.” That ...
... by K M Shah Dental College an eye wash and ... admission //process by with a supposed entrance test held by ... for granting admissions. ,The court, had issued a ... admission should continue and has asked the Gujarat University (GU) ...
... Quebec say that chronic job stress can raise blood ... ,The research, appearing in the American Journal of ... deadlines increased blood pressure especially in men. The study ... study supports the hypothesis that job strain, particularly in ...
Cached Medicine News:Health News:Klebsiella Outbreak In Durban Blamed On Staff Shortage & Overcrowding 2Health News:Gujarat High Court Stays PG Admissions In A Private Dental Collage 2
(Date:7/29/2014)... July, 29  2014 ISPE—the International Society for ... John Bournas as President and CEO, succeeding ... leave the Society last fall.  Mr. Bournas takes ... the healthcare association industry as well as significant ... clear vision for the expansion of its global ...
(Date:7/29/2014)... HILL, Conn. , July 29, 2014 Numotion,s ... 2014, Mike Swinford will be the company,s new ... a highly successful 22-year career at GE where he worked ... million in annual revenue to over $5 billion. His most ... Global Services. "I am thrilled to join ...
(Date:7/29/2014)... and NEW YORK , ... of the executive management team of Caremark Rx, ... Media ( www.pbm365.com ).  PBM365 is the leading independent ... reporting, insight, analysis and opinion on the pharmacy ... will provide insightful and timely coverage of, and context ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3Numotion Names Mike Swinford CEO 2Drew Crawford Announces Launch of PBM365 Media 2
... published in the American Journal of Nephrology -, ... announced that its Phase III data on VAPRISOL was ... Nephrology. In this study,VAPRISOL showed a significant increase in ... life-threatening condition that,occurs when the body,s sodium level falls ...
... Cancer patients at Beaumont,Hospitals are the first in the ... therapy that is painless, faster, more accurate and precise,than ... patented the new,technology, Omnibeam(R). The $3.3-million machine is manufactured ... first patient,was treated on Sept. 10. The painless ...
Cached Medicine Technology:Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 2Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 3Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 5Beaumont Patients 1st to get Next Generation of Radiation Treatment 2
... formula is the most convenient multi-purpose no ... one bottle without the need to rub: ... lenses and removes protein build-up when used ... contains Hydranate, a special ingredient that removes ...
Half Trial Frames with precision engineering and lightweight material....
Half Eye Trial Frame - Child...
Non Sterile surgical blade....
Medicine Products: